Posted on 9/26/19
Currax Pharmaceuticals Acquires North American Rights to ONZETRA Xsail
Currax Pharmaceuticals LLC, a specialty biopharmaceutical company with both Branded and generic business units, announced today a deal whereby Currax obtained patent rights to ONZETRA Xsail (sumatriptan . . .
Posted on 9/26/19
Dialyze Direct Expands Dialysis Services into Maryland
On the heels of its recent expansion into Indiana, Dialyze Direct today announced the official expansion of its proprietary geriatric in-home dialysis model to the state . . .
Posted on 9/25/19
St. Joseph's Health and Hackensack Meridian Health Announce Clinical and Strategic Partnership
St. Joseph's Health, a world-class hospital and healthcare network, and Hackensack Meridian Health, New Jersey's largest and most comprehensive and integrated health network, today announced the . . .
Posted on 9/25/19
Citius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-Market
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the pricing of an underwritten . . .
Posted on 9/24/19
Enhanced Healthcare Partners Announces Closing of New Fund
NEW YORK--(BUSINESS WIRE)--Enhanced Healthcare Partners, a leading New York-based private equity firm focused on investing in middle-market healthcare businesses, announced today the closing of Enhanced Healthcare . . .
Posted on 9/24/19
Provention Bio Reiterates Regulatory Strategy for PRV-031 and Announces Completion of Follow-on Financing
Provention Bio, Inc., (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reiterated its regulatory strategy regarding PRV-031 (teplizumab) for the . . .
Posted on 9/24/19
Bioasis Announces Proposed Private Placement
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the . . .
Posted on 9/23/19
GenScript Partners with Harvard University
GenScript, the world's leading gene synthesis provider, today announced that it will provide research support to Harvard University scientist George Church, PhD, for his contributions to . . .
Posted on 9/23/19
Mercer and Xevant Announce Strategic Plan Optimization Solution for Employer-Sponsored Pharmacy Benefit Plans
NEW YORK & SALT LAKE CITY--(BUSINESS WIRE)--Mercer, a global consulting leader in advancing health, wealth and career, and Xevant, a leader in pharmacy benefit management (PBM) . . .
Posted on 9/23/19
Cantel Medical Reports Financial Results for its Fourth Quarter Fiscal Year 2019
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2019.Fourth quarter 2019 net sales were $239.5M, up 4.6% compared . . .
Posted on 9/23/19
Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today the extension of the expiration date of the offers to exchange notes issued by Celgene Corporation (NASDAQ:CELG) for . . .
Posted on 9/23/19
Johnson & Johnson: Opportunity Beckons - Know When To Strike
SummaryJohnson & Johnson's current low share price reflects fear in the market of large opioid-related claims.These claims are highly manageable from a financial perspective.It's rare to . . .
Posted on 9/23/19
Johnson & Johnson Portfolio: Halftime Report
SummaryIn June, I presented a bulletproof, or hedged, portfolio around a position in Johnson & Johnson.This portfolio was designed to last six months. Here, I show . . .
Posted on 9/23/19
3 Biotechs With the Biggest Cash Stockpiles
Cold, hard cash. Getting it is frequently one of the main challenges for biotechs, particularly those with no approved products. But several of the largest biotechs . . .
Posted on 9/22/19
Schizophrenia Clinical Research Receives NIMH Funding to Improve Treatment
Feinstein Institutes for Medical Research scientists have been awarded a five-year, $7.3 million National Institutes of Mental Health (NIMH) grant to support their research in improved . . .
Posted on 9/22/19
Yesse Technologies Awarded $750K SBIR Phase II Grant From The National Science Foundation
Yesse Technologies, Inc. (formerly MouSensor), a New York-headquartered biotechnology company, has been awarded a $750,000 National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II . . .
Posted on 9/22/19
Celgene Corp. Names Second Round of Celgene Cancer Care Links Program Grant Recipients
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced an additional ten programs selected for funding under its Celgene Cancer Care Links™ program, an initiative designed to . . .
Posted on 9/22/19
ARS Treatment Centers Announces Two New Office-Based Opioid Treatment Clinics in New Jersey
NEWARK, N.J. & GREENVILLE, S.C.--(BUSINESS WIRE)--ARS Treatment Centers, a national leader in Office-Based Opioid Treatment (OBOT), announced today that it is continuing its expansion in New . . .
Posted on 9/20/19
Johnson & Johnson: Opportunity Beckons - Know When To Strike
SummaryJohnson & Johnson & Johnson's current low share price reflects fear in the market of large opioid-related claims.These claims are highly manageable from a financial perspective.It's . . .
Posted on 9/19/19
Medicrea Reports First Half 2019 Financial Results
LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the digital transformation of spinal surgery through artificial . . .
Posted on 9/19/19
New Jersey Urology Partners with Premier Urology Group
New Jersey Urology, the leading urology service provider in New Jersey, and Urology Management Associates are pleased to announce a partnership with Premier Urology Group LLC, . . .
Posted on 9/18/19
PTC Therapeutics Prices Public Offering of Common Stock
PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today the pricing of a public offering of 2,475,248 shares of its common stock at a public offering price of . . .
Posted on 9/18/19
The Beekman Group Partners with Twin Boro Physical Therapy
NEW YORK--(BUSINESS WIRE)--Effective August 28th, 2019, Twin Boro Physical Therapy Associates, P.A.has partnered with The Beekman Group, a New York based private equity firm dedicated to . . .
Posted on 9/18/19
IQVIA Collaborates with Cancer Researchers
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) is proud to announce its collaboration with Friends of Cancer Research in a cross-industry effort to advance . . .
Posted on 9/18/19
PTC Therapeutics Proposes Public Offering of Common Stock
PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that it is commencing a public offering of $100.0 million of shares of its common stock. PTC intends to . . .

